These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22690152)
21. Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives. Sadeghi-Aliabadi H; Tabarzadi M; Zarghi A Farmaco; 2004 Aug; 59(8):645-9. PubMed ID: 15262534 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of 3-substituted indenoisoquinoline derivatives as topoisomerase I inhibitors. Zhao Q; Xu X; Xie Z; Liu X; You Q; Guo Q; Zhong Y; Li Z Bioorg Med Chem Lett; 2016 Feb; 26(3):1068-1072. PubMed ID: 26725027 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374 [TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors. Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells. Jin GZ; Jin HS; Jin LL Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro evaluation of 1,8-diazaanthraquinones bearing 3-dialkylaminomethyl or 3-(N-alkyl- or N-aryl)carbamoyloxymethyl substituent. Lee H; Lee SI; Cho J; Choi SU; Yang SI Eur J Med Chem; 2003; 38(7-8):695-702. PubMed ID: 12932900 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives. Wei BL; Wu SH; Chung MI; Won SJ; Lin CN Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407 [TBL] [Abstract][Full Text] [Related]
28. 2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity. Tam MN; Nam NH; Jin GZ; Ahn BZ Arch Pharm Res; 2000 Aug; 23(4):283-7. PubMed ID: 10976572 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives. Nebois P; do Nascimento SC; Boitard M; Bartoli MH; Fillion H Pharmazie; 1994 Nov; 49(11):819-21. PubMed ID: 7838868 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and cytotoxicity of longistylin C derivatives. Shan Y; Hong T; Wang YF; Zhang NL; Yu B; Lu Y; Qiu SX Chin J Nat Med; 2015 Apr; 13(4):311-5. PubMed ID: 25908631 [TBL] [Abstract][Full Text] [Related]
31. Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway. Chen WS; Hou JN; Guo YB; Yang HL; Xie CM; Lin YC; She ZG J Exp Clin Cancer Res; 2011 Feb; 30(1):17. PubMed ID: 21303527 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and antitumor evaluation of symmetrical 1,5-diamidoanthraquinone derivatives as compared to their disubstituted homologues. Huang HS; Chiu HF; Tao CW; Chen IB Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):458-64. PubMed ID: 16595945 [TBL] [Abstract][Full Text] [Related]
34. Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents. Lee YR; Chen TC; Lee CC; Chen CL; Ahmed Ali AA; Tikhomirov A; Guh JH; Yu DS; Huang HS Eur J Med Chem; 2015 Sep; 102():661-76. PubMed ID: 26344783 [TBL] [Abstract][Full Text] [Related]
35. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives. Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494 [TBL] [Abstract][Full Text] [Related]
36. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties. Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents. Hu K; Qi YJ; Zhao J; Jiang HF; Chen X; Ren J Eur J Med Chem; 2013 Jun; 64():529-39. PubMed ID: 23685571 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives. Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185 [TBL] [Abstract][Full Text] [Related]
39. Grincamycins I - K, Cytotoxic Angucycline Glycosides Derived from Marine-Derived Actinomycete Streptomyces lusitanus SCSIO LR32. Lai Z; Yu J; Ling H; Song Y; Yuan J; Ju J; Tao Y; Huang H Planta Med; 2018 Feb; 84(3):201-207. PubMed ID: 28950383 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors. Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]